News | September 17, 2024
Merck and Siemens partner on digital transformation technology
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
TROPION-Lung01, evaluating AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan versus chemotherapy, previously met the dual primary endpoint of progression-free survival in the overall trial population
The collaborations will help curate industry focused courses such as Advanced Certification courses for healthcare professionals in Healthcare Marketing, Healthcare Technology and Specialized Clinical Fellowship Level programs with university accreditation
The patient has been isolated in a designated hospital and is currently stable
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Konieczny has served as Interim CEO since April 2024
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
